Community Health Worker Education for COVID-19
Trial Summary
What is the purpose of this trial?
The proposed project will implement and evaluate a brief Community Health Worker (CHW) intervention through the Albany Area Primary Health Care, a rural Federally Qualified Health Center (FQHC). The primary goal of this study is to maximize effective outreach, education, and communication through CHWs in order to facilitate improved COVID-19 vaccine confidence and uptake in underserved and vulnerable communities. CHWs will be deployed to the homes of adults with increased risk of morbidity and mortality (i.e., African Americans or Latinos with uncontrolled diabetes or prediabetes, age \<50 years, and non-COVID-19 vaccinated) in order to educate them about diabetes, COVID-19 and related vaccines. Health assessments, including blood glucose measurement, will be conducted on the indexed patient and offered to all other adult family members in the household (i.e., "bubble"). Adults with Type 2 diabetes likely live in households with other adults who have or are at increased risk for diabetes (i.e., prediabetes and obesity).1 It is expected that they will also share similar COVID-19 exposure risk. The specific aims are to: 1) Evaluate a community-driven education program to increase and enhance COVID-19 vaccine confidence and uptake in individuals with uncontrolled diabetes and their families (i.e., their "bubble") and 2) Evaluate a community-driven education program to improve diabetes self-management behaviors and related outcomes (e.g., blood glucose) in individuals with uncontrolled diabetes in rural, Southwest Georgia.
Research Team
Rakale C Quarells, PhD
Principal Investigator
Morehouse School of Medicine
Eligibility Criteria
This trial is for African American or Latino adults under 50 with uncontrolled diabetes or prediabetes, who have not been vaccinated against COVID-19 (for Phase 1) and are patients within the AAPHC community sites. It excludes those with severe psychological disorders, terminal cancer, chronic kidney disease stages 4-5, pregnant women, and individuals unable to consent.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
CHW Intervention
A six week CHW home-visit behavioral intervention examining changes in diabetes outcomes and COVID-19 vaccine confidence
Follow-up
Participants are monitored for changes in blood glucose levels and COVID-19 vaccination confidence after the intervention
Treatment Details
Interventions
- Impact of Community Health Worker Home Deployment on COVID-19 Vaccine Confidence and Uptake
Find a Clinic Near You
Who Is Running the Clinical Trial?
Morehouse School of Medicine
Lead Sponsor